Automated Cell Shakers Market Eyes US$ 899.0 Million by 2034, Predicts 3.7% CAGR

Comments · 206 Views

This market surge is indicative of a transformative shift in laboratory practices, with automated cell shakers playing a pivotal role in enhancing efficiency and precision in various scientific and biomedical applications.

Over the course of the forecast period, the automated cell shakers market is anticipated to rise at a compound annual growth rate (CAGR) of 3.7%. The market value is expected to increase dramatically, from US$ 626.1 million in 2024 to a noteworthy US$ 899.0 million by 2034.

Certain technological advancements in automated cell shakers are occurring as a result of the rising need for advanced cell culture technologies in fields like virology, cancer research, and vaccine development, among others. As a result, industry participants using cell culture equipment are employing a variety of technological advancements to expand their businesses in numerous ways.

For instance, in March 2022, the ES-20/80C orbital shaker-incubator with cooling was launched by SIA Biosan. The platform motion mechanism is a newly invented triple eccentric mechanism that delivers superlative balancing features, excellent reliability, and silent operation.

Seize Excellence Today: Claim Your Sample for Unmatched Efficiency:

https://www.futuremarketinsights.com/reports/sample/rep-gb-18542

This increased productivity encourages the adoption of automated cell shakers as a valuable component of the lab automation process. Lab automation systems are designed to streamline and automate laboratory processes, including tasks like cell culture and cell shaking. By integrating automated cell shakers into these systems, laboratories can achieve higher levels of efficiency and throughput.

For instance, in September 2022, the Eppendorf Group expanded its bioprocess site in Jülich, Germany, by constructing a new cutting-edge multifunctional building. This includes the adoption of cutting-edge equipment for the multifunctional facility. The technical equipment in the advanced bioprocess building creates the framework for Jülich to remain a leader in developing and producing bioprocess goods and bioprocess software solutions.

Key Takeaways:

• By product, the orbital shakers hold a lucrative CAGR value of 3.6% with a market share value of 33.0%, as orbital shakers can be easily integrated into automated systems, contributing to the overall trend of laboratory automation.

• Automating cell culture processes, including monitoring, contributes to overall efficiency in drug development workflows. Drug development holds a significant market share value of 36.6% in 2024.

• By cell culture type, the infinite cell culture segment is expected to hold over 69.6% market value share by the end of 2034, as infinite cell lines are commonly used in high-throughput screening for drug discovery.

• By end user, the biopharmaceutical companies segment holds a market share value of 28.4% in 2023.

• North America is the leading region with a value share of 37.5%, owing to its increasing bio-manufacturing capabilities.

“The comprehensive analysis highlights key trends, technological advancements, and competitive dynamics, providing valuable insights for industry stakeholders and potential investors interested in navigating the evolving dynamics of the automated cell shakers market.” – says Sabyasachi Ghosh, Associate Vice President at Future Market Insights (FMI)

Competitive Landscape:

Collaborations, significant investment in research institutions for innovative technology, and the introduction of advanced products enhance the presence of manufacturers in merging countries. Moreover, key players are actively involved in joint ventures and licensing agreements to develop and integrate complementary technologies.

• In March 2023, Kuhner Shaker announced the completion and equipping of its new manufacturing hall at the headquarters in Birsfelden, Switzerland.

• In March 2023, Thermo Fisher introduced the Thermo Scientific Solaris Benchtop Temperature Controlled Orbital Shakers.

• In September 2022, Danaher Corporation merged two companies, Cytiva and Pall Life Sciences, to work on bioprocessing workflows.

Leading Key Players:

• Kuhner Shaker

• Infors AG

• Thermo Fisher Scientific

• Esco Micro Pte. Ltd.

• Corning Incorporated

• Labtron Equipment Ltd.

• Danaher Corporation

• LabStrong

• Bio-Rad Laboratories

• Merck KGaA

• Sartorius AG

• Hamilton Medical AG

• Miltenyi Biotec

• Eppendorf SE

• Heidolph Instruments GmbH & CO. KG

• Inheco Industrial Heating & Cooling GmbH

• SIA Biosan

• BIOBASE GROUP

• Boekel Scientific

• Eberbach

• Grant Instruments

• OPTIMA Inc.

Automated Cell Shakers Market Segmentation:

By Product:

• Automated Cell Shakers

• Orbital Shakers

• Ambient Shakers

• Orbital Double Decker Shakers

• Orbital Triple Decker Shakers

• Benchtop Incubator Shakers

• Cell Shaker with Rotatory Arms

• Accessories

By Cell Culture Type:

• Finite Cell Line Cultures

• Infinite Cell Line Cultures

By Application:

• Cell Therapy

• Drug Development

• Stem Cell Research

• Regenerative Medicine

By End User:

• Mega Pharmaceutical Companies

• Biopharmaceutical Companies

• CDMOs/CMOs

• Research Organizations

• Academic Institutes

• Hospitals (Providing Cell Therapy/Regenerative Medicine)

By Region:

• North America

• Latin America

• East Asia

• South Asia

• Europe

• Oceania

• The Middle East and Africa

Comments